摘要
我院自1990年元月至1993年10月采用砂冰莪术酊剂对36例原发性肝癌(以下简称HCC)的晚期疼痛进行了治疗,近期效果满意,现作一初步报道。 材料与方法 一、临床资料:本组36例中,男性33例,女性3例,年龄14~76岁,平均45岁,均为晚期病例。对照组15例,其中男性13例,女性2例,两组临床条件大致相同。所有患者均符合1978年杭州会议制订的晚期肝癌诊断标准,经AFP、US、CT或手术病理证实,且无条件作手术。 二、疗效判定:疼痛缓解时间以给药后疼痛开始缓解至下次疼痛开始出现的间隔为准。
Thirty-six late hepatocellular carcinoma (HCC) patients with pain treated with the TVBR locally were studied. The results showed that the TVBR has a more stronge analgesic action and maintaining a long effective time for relieving the pain, when compaired with 15 controls of late HCC patients with pain treated with Dolantin (merperidine hydrochloride). It is suggested that the TVBR is a safe, low-priced and non-addiction effective analgesics for relieving the pain of late HCC patients.
出处
《中西医结合肝病杂志》
CAS
1994年第2期43-43,共1页
Chinese Journal of Integrated Traditional and Western Medicine on Liver Diseases
关键词
原发性肝癌
中医药疗法
砂冰莪术酊
Vermilion Cinnabar Broneolum Syntheticum Rhizoma Zedoariae Hepatocellular carcinoma Pain Tincture/therapeutic use